Shilpa Medicare’s equal joint venture with Zydus group - Oncosol - along with its partner company Shorla Oncology, has announced USFDA's approval for IMKELDI, the first oral liquid form of imatinib to ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) has been assigned an average rating of “Buy” from the five brokerages that are currently covering the firm, Marketbeat reports. Four equities ...

Tenax also is developing a unique oral formulation of imatinib. For more information, visit Tenax’s common stock is listed on The Nasdaq Stock Market LLC under the symbol “TENX”.

Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

We believe IkT-001Pro, a prodrug of imatinib, has the potential to ameliorate the safety and tolerability profile that precluded approval of imatinib for the treatment of PAH more than 10 years ago.

Consumer prices rose 0.2% last month and were up 2.6% from the year before, according to the latest Consumer Price Index data released Wednesday by the Bureau of Labor Statistics. Housing-related ...

Impact Link As expected by economic forecasters, inflation heated up in October. The consumer price index sped up as expected to a 2.6% year-over-year growth rate in October from September's rate ...

The data snapped a streak of six consecutive months of cooling inflation. Consumer prices rose 2.6% in October compared to a year ago, ticking upward from the previous month and reversing some of ...

OPEC cuts oil demand growth forecast for 2024, 2025 US dollar rises to 4-month high against other currencies Nov 12 (Reuters) - Oil prices held near a two-week low on Tuesday after dropping about ...